<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - FDA Issues Guidelines on COVID-19 Trials
Image Overlay - FDA Issues Guidelines on COVID-19 Trials

FDA Issues Guidelines on COVID-19 Trials

FDA Issues Guidelines on COVID-19 Trials

The FDA released a new set of guidelines for potential coronavirus vaccines, noting that they must be at least 50% effective in a placebo-controlled trial.“While the FDA is committed to help expedite this work, we will not cut corners in our decision making and we are making clear in our guidance what are the data we need that should be submitted to meet our regulatory standards for approval,” said FDA Commissioner Stephen Hahn, MD. The race to bring a treatment and a vaccine from trials to market is underway, and Yourway has been there since the beginning of the pandemic, in support of all clinical trial needs.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat
Come chat with us!
Hello! How can I help you?